Silver Book reference

Memantine in Moderate-to-Severe Alzheimer’s Disease

1 Matching Fact

Search matching Facts:
No results to display
    • A recent study showed that memantine, a medicine approved to treat moderate-to-severe Alzheimer’s, significantly slows cognitive decline and reduces the need for caregiving by 45.8 hours per month.